Mark Massaro
Stock Analyst at BTIG
(2.20)
# 2,477
Out of 4,670 analysts
137
Total ratings
44.86%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXAS Exact Sciences | Maintains: Buy | $82 → $65 | $52.91 | +22.85% | 15 | Nov 6, 2024 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $7 → $8 | $4.69 | +70.58% | 4 | Oct 2, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $0.22 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $7.18 | -2.51% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $3.47 | +101.73% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $176.96 | +27.15% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $167.26 | -19.29% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $2.11 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $78.71 | -42.83% | 4 | Jul 31, 2024 | |
| GH Guardant Health | Maintains: Buy | $45 → $50 | $32.65 | +53.14% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $417.24 | +39.01% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $16.39 | +28.13% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $3.55 | +125.35% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.33 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $1.88 | +325.53% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.20 | +150.00% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $29.81 | +0.64% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.10 | +21.95% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $23.13 | +8.08% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.79 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.00 | +250.35% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.51 | - | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $2.71 | +3,590.04% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.64 | - | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $140.14 | +114.07% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $78.97 | -36.68% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $163.59 | -31.54% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $239.67 | -31.16% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $40.14 | +99.30% | 9 | Sep 10, 2018 |
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $65
Current: $52.91
Upside: +22.85%
Adaptive Biotechnologies
Oct 2, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $4.69
Upside: +70.58%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.22
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $7.18
Upside: -2.51%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $3.47
Upside: +101.73%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $176.96
Upside: +27.15%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $167.26
Upside: -19.29%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $2.11
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $78.71
Upside: -42.83%
Guardant Health
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $32.65
Upside: +53.14%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $417.24
Upside: +39.01%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $16.39
Upside: +28.13%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $3.55
Upside: +125.35%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.33
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $1.88
Upside: +325.53%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.20
Upside: +150.00%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $29.81
Upside: +0.64%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.10
Upside: +21.95%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $23.13
Upside: +8.08%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.79
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.00
Upside: +250.35%
Jul 7, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.51
Upside: -
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $2.71
Upside: +3,590.04%
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $1.64
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $140.14
Upside: +114.07%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $78.97
Upside: -36.68%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $163.59
Upside: -31.54%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $239.67
Upside: -31.16%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $40.14
Upside: +99.30%